Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is zervimesine, an orally...
35 insider purchases on record · latest filing 2026-04-20.
Insiders have also filed 5 sale transactions at CGTX.